Literature DB >> 7299373

Protein synthesis in Vero cells abortively infected with influenza B virus.

K Nakamura, M Homma.   

Abstract

Growth of influenza B virus was found to be greatly restricted in Vero cells compared with that in MDCK cells. The analysis of protein synthesis in infected cells showed that the synthesis of M protein is selectively inhibited in abortive infection. Cell fractionation experiments demonstrated that the viral glycoproteins, HA and NA, migrate from rough membranes via smooth membranes to plasma membranes in abortive as well as in productive cells. These results suggest that intracellular migration of influenza B virus glycoproteins occurs independently of the synthesis of M protein although M protein synthesis appears to be required for the formation of virus particles.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7299373     DOI: 10.1099/0022-1317-56-1-199

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  8 in total

Review 1.  Cell culture-based influenza vaccines: A necessary and indispensable investment for the future.

Authors:  Nagendra R Hegde
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  Synthesis of M protein of influenza B virus is specifically inhibited at a non-permissive temperature.

Authors:  K Tobita; T Tanaka; H Goto; S Feng
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

3.  African green monkey kidney (Vero) cells provide an alternative host cell system for influenza A and B viruses.

Authors:  E A Govorkova; G Murti; B Meignier; C de Taisne; R G Webster
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

4.  Influenza virus pathogenicity is determined by caspase cleavage motifs located in the viral proteins.

Authors:  Oleg P Zhirnov; Vladimir V Syrtzev
Journal:  J Mol Genet Med       Date:  2009-01-03

5.  A Y161F Hemagglutinin Substitution Increases Thermostability and Improves Yields of 2009 H1N1 Influenza A Virus in Cells.

Authors:  Feng Wen; Lei Li; Nan Zhao; Meng-Jung Chiang; Hang Xie; Jim Cooley; Richard Webby; Peng George Wang; Xiu-Feng Wan
Journal:  J Virol       Date:  2018-01-02       Impact factor: 5.103

Review 6.  Cell-based influenza vaccines: progress to date.

Authors:  Jennifer M Audsley; Gregory A Tannock
Journal:  Drugs       Date:  2008       Impact factor: 9.546

7.  Generation of high-yielding influenza A viruses in African green monkey kidney (Vero) cells by reverse genetics.

Authors:  Hiroichi Ozaki; Elena A Govorkova; Chenghong Li; Xiaoping Xiong; Robert G Webster; Richard J Webby
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

8.  Immunogenicity and Safety of Trivalent Split Influenza Vaccine in Healthy Korean Adults with Low Pre-Existing Antibody Levels: An Open Phase I Trial.

Authors:  Kyuri Kang; Seunghoon Han; Taegon Hong; Sangil Jeon; Jeongki Paek; Jin Han Kang; Dong Seok Yim
Journal:  Yonsei Med J       Date:  2016-11       Impact factor: 2.759

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.